Onychomycosis: Clinical perspective

International Journal of Dermatology

Volumn 39, Issue 4, 2000, Pages 241-249

  Sehgal, Virendra N ^a   Jain, Sanjeev ^b  

^a Sehgal Nursing Home   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGENICITY; BACTERIAL INFECTION; CANDIDA; CANDIDIASIS; CLINICAL FEATURE; DERMATOPHYTE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; FUSARIUM; HUMAN; LICHEN PLANUS; NONHUMAN; ONYCHOMYCOSIS; PARONYCHIA; PSORIASIS; QUALITY OF LIFE; REVIEW;

DIAGNOSIS, DIFFERENTIAL; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; ONYCHOMYCOSIS;

EID: 0034069320     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00812.x     Document Type: Review

References (54)

1. Jones HE, Reinhard JH, Kinaldi MG. A clinical, mycological and immunological survey for dermatophytosis. Arch Dermatol 1973; 108: 61-65.
2. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis, and tinea manuum caused by non-dermatophyte filamentous fungi. Mycoses 1989; 32: 609-619.
3. Zaias N. Onychomycosis. Arch Dermatol 1972; 105: 273.
4. Allan HB, Rippon JW. Superficial and deep mycoses. In: Moschella SL, Hurely HJ, eds. Dermatology, 2nd edn. Philadelphia: W.B. Saunders, 1985: 739-816.
5. Elewski BE. Proximal white suhungual onychomycosis in acquired immunodeficiency syndrome. J Am Acad Dermatol 1993; 29: 631-632.
6. Elewski BE. Common superficial mycoses. In: Arndt TA, Leboit PE, Robinson JK, Wintroub B, eds. Cutaneous Medicine and Surgery, Vol. 2. Philadelphia: W.B. Saunders, 1996: 1037-1055.
7. Haenek E. Fungal infections of the nail. Semin Dermatol 1991; 10: 41-53.
8. Hay RJ. Fungi and Skin Diseases. London: Wolfe Publishing, 1993: 30.
9. Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994; 130: 515.
10. Odom R. Pathophysiology of dermatophyte infections. J Am Acad Dermatol 1993: 28: 25-75.
11. Lubeck DP, Patrick DL, McNutty P, et al. Quality of life of persons with onychomycosis. Dual Life Res 1993; 2: 341-348.
12. Drake L. Onychomycosis and quality of life. 2nd International Symposium on Onychomycosis, Florence, Italy, September 28-29, 1995.
13. Drake L. Quality of life issues for patients with fungal nail infections. AIDS Patient Care 1995; 9: 515-517.
14. Haneke E. Onychomycosis and quality of life: a multinational study. 4th Congress of the European Academy of Dermatology and Venereology, Brussels, Belgium, 1995.
15. Shear NH, Gupta AK. Terbinafine for the treatment of pedal onychomycosis; a foot closer to the promised land of cured nails. Arch Dermatol 1995; 131: 937-942.
16. Stary A, Torma S. Quality of life in onychomycosis patients. 2nd International Symposium on Onychomycosis, Florence, Italy, September 28-29, 1995.
17. Drake LA. Impact of onychomycosis on quality of life. J Am Pod Med Ass 1997; 87: 507-571.
18. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997; 36: 745-756.
19. Whittman LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997; 22: 87-89.
20. Lubeck DP. Measuring health related quality of life on onychomycosis. J Am Acad Dermatol 1998; 38: 564-568.
21. Trepainer EF, Amsden GW. Current issues in onychomycosis. Ann Pharmacother 1998; 32: 204-214.
22. Leib SL. Recurrent erysipelas - tinea pedis et linguium - chronic venous insufficiency. Schweiz-Rundsch Med Prax 1994; 83: 1089-1090.
23. Haneke E. Onychomycosis and psoriasis of the nails - indistinguishable? Annual meeting of the American Academy of Dermatology, Dallas, TX, December 7-12, 1991.
24. Sorensen GW, Jones HE. Immediate and delayed hypersensitivity in chronic dermatophytosis. Arch Dermatol 1976; 112: 40-42.
25. Blake JS, Dahl MV, Herron MJ, Nelon RD. An immunoinhibitory cell wall glycoprotein (mannan) from Trichophyton rubrum. J Invest Dermatol 1991; 96: 657-661.
26. MacCarthy KG, Blake JS, Johnson KL, et al. Dermatophyte-responsive T-cell lines recognize cross reactive antigens associated with mannose-rich glycoproteins. Exp Dermatol 1994; 3: 66-71.
27. Daniel CR III, Norton LA, Scher RT. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27: 93-97.
28. Elinets CA. Management of common superficial fungal infection in patients with AIDS. J Am Acad Dermatol 1994; 31: 560-563.
29. Gregory N. Special patient populations: onychomycosis in the HIV-positive patient. J Am Acad Dermatol 1996; 35: 513-516.
30. Herranz P, Garcia J, De Lucas R, et al. Toe nail onychomycosis in patients with acquired immunodeficiency syndrome: treatment with terbinafine. Br J Dermatol 1997; 137: 577-580.
31. Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol 1996; 35: 510-512.
32. Shuster S, Fisher GH, Harous E, Binnell D. The effect of skin disease on self image. Br J Dermatol 1978; 97: 18-19.
33. Shuster S. Depression of self-image by skin disease. Acta Derm Venereol (Stockh.) Suppl 1991; 71: 156-153.
34. Urbanowski S, Kosmowski W, Gwiezdzinski Z, Araszkiewicz A. Quality of life and depression among patients with onychomycosis. Clinical Dermatology 2000, Singapore, 1998.
35. Marchetti A, Piech CT, Ghan WF, et al. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. Clin Therap 1996; 18: 757-777.
36. Girmenia C, Areese W, Micozzi W, et al. Onychomycosis as a possible origin of disseminated Fusarium spp infection in a patient with severe aplastic anemia (Letter). Clin Infect Dis 1992; 141: 1167.
37. Nelson PE, Dignani MC, Anaisie EJ. Taxonomy, biology and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504.
38. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infection in immunocompromised patients. J Infect 1994; 18 (Suppl 1): 7-15.
39. Arrese JE, Pierard-Franchimont C, Pierard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996; 18: 196-198.
40. Al-Sogair SM, Rahi AH, Moawad MK, Hay RJ. Electrophoretic protein profile of dermatophytes and its correlation with specific IgE in acute and chronic dermatophytosis. J Eur Acad Dermatol Venereol 1990; 5 (Suppl 1): 815.
41. Schwartz HJ, Ward GW. Onychomycosis, Trichophyton allergy and asthma - a casual relationship. Ann Allergy Asthma Immunol 1995; 74: 523-524.
42. Meinhof W. Tinea unguium. In: Korting GW, ed. Dermatologic in Klinik and Praxis, Vol. 2. Stuttgart, Germany: Thieme, 1980: 19.4-19.5
43. Achten G, Wanet-Ronard J. Onychomycosis in the laboratory. Mykosen 1978; 23: 125-127.
44. Andre J, Achten G. Onychomycosis. Int J Dermatol 1987; 26: 481-490.
45. Basuk PJ, Scher RK, Ricci AR. Dermatologie disease of the nail unit. In: Scher RK, Daniel CR III, eds. Nails: Therapy, Diagnosis, Surgery, 2nd edn. Philadelphia: W.B. Saunders, 1997: 127-152.
46. Daniel CR III. Inflammatory nail disorders. In: Daniel CR III, ed. Diagnosis of Onychomycosis and Other Nail Disorders. New York: Springer-Verlag, 1995: 6-45.
47. Elewski BE. Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 1996; 35: 56-59.
48. Saurez SM, Silvers DN, Scher RK, et al. Histologic evaluation of nail clippings for diagnosis of onychomycosis. Arch Dermatol 1991; 127: 1517-1519.
49. Zaias N. Onychomycosis. Dermatol Clin 1985; 3: 445-460.
50. Arrese JE, Pierard-Franchimont C, Greimer S, Pierard GE. Fungi in onychomycosis. A study by immunohistochemistry and dual flow cytometry. J Eur Acad Dermatol Venereol 1995; 4: 123-130.
51. Pierard GE, Arrese JE, De Doncker P, et al. Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol 1996; 34: 273-277.
52. Pierard GE, Arrese JE, Pierard-Franchimont C, et al. Heterogeneity in fungal nail infections and life threatening onychomycosis. Br J Dermatol 1994; 131: 805.
53. Pierard GE, Arrese JE, Pierre S, et al. Diagnostic microscopique des onychomycosis. Ann Dermatol Venereol 1994; 121: 25-29.
54. Clayton Y. Clinical and mycological diagnostic aspects of onychomycosis and dermatomycosis. Clin Exp Dermatol 1992; 17 (Suppl 1): 37-40.